mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.2 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.2 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.2 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.3 |